News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
byStephen Padilla
The extended-release combination of naltrexone and bupropion (NB-ER) may be used as safe and effective treatment for weight reduction among individuals with overweight/obesity and mild to moderate symptoms of depression, suggests a study.
Naltrexone–bupropion a safe weight-loss treatment for persons with obesity, depression
08 May 2026
Brolucizumab a viable alternative in proliferative diabetic retinopathy
02 May 2026
byJairia Dela Cruz
In the treatment of patients with proliferative diabetic retinopathy, brolucizumab outperforms panretinal laser photocoagulation in terms of preserving visual acuity, according to the international phase III CONDOR trial.







